User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Jan 25 2015 22:40 IST RSS 2.0
 
1 to 20 of 2,530    
India, US to enhance engagement on IPR 25.1.2015 Rediff: Business
India and the US on Sunday agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries.
Also found in: [+]
IPR and the great drug pricing dilemma 25.1.2015 TOI: India Business
The Obama visit could prove crucial for India's healthcare system. Intellectual property rights is listed as a priority area for discussion between the two nations, officials said.
Also found in: [+]
World backs India against ‘bully’ US 25.1.2015 TOI: Home
Apprehensive of the US exerting pressure on India to dilute the public health safeguards in its patent laws, organizations from across the world have signed a global petition supporting India’s patent law and urging India to stand strong in the face of “US bullying”.
Also found in: [+]
Government looks at Narendra Modi's charisma to strike deals with Obama 24.1.2015 DNA: Popular News
Even as the 'fortress' Delhi awaits US President Barack Obama, as well as First Lady Michelle Obama, officials here are banking on Prime Minister Narendra Modi's charisma to strike deals on key issues during the informal talks. It has appeared over past few days that glitches continue to haunt officials from both sides over a range of issues including climate change, totalisation, Visa, labour laws and intellectual property right (IPR), new defence cooperation agreement or revisiting liability regimes in the nuclear energy issue. The Prime Minister will get opportunities at least seven times during the next three days to hold informal discussions with the visiting US President, besides a formal bilateral dialogue that takes place in Hyderabad House here Sunday afternoon. Both will come face-to-face at least on seven different occasions between Sunday and Tuesday. Experts here believe Modi will also have to do a fine balancing act between regaling Americans and not succumbing to their pressures with ...
Also found in: [+]
India's patent laws under threat? 24.1.2015 India News, Latest News in India, Live News India, India Breaking News - Times of India
Setting up of a bilateral mechanism on intellectual property (IP) rights through the US-India trade policy forum and the new draft national IP policy championing IP as the only way to promote innovation have raised apprehensions among health activists that India might concede ground on IP during President Obama's ...
Also found in: [+]
Patients' groups voice patent fears 24.1.2015 Telegraph: Nation
Health and patients' rights groups have called on the government to resist American pressure that they claimed was aimed at weakening safeguards in India's patent laws that allow drug companies to sell inexpensive generic medicine.
Also found in: [+]
Government may negotiate price of patented drugs before market entry 23.1.2015 ET: Pharma
The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India.
Also found in: [+]
Govt may negotiate price of drugs before market entry 23.1.2015 TOI: India
The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in ...
Also found in: [+]
Setback to Natco as US SC sends Teva case for review 22.1.2015 TOI: Cities
In a setback to homegrown pharma player Natco, the US Supreme Court has sent back the patent case related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit, which hears appeals in patent, trademark and trade-related ...
Also found in: [+]
‘Obama visit will pressurize India to alter patent law to suit US interests’ 21.1.2015 TOI: India
US President Barack Obama’s visit has set alarms bells ringing among those working to improve access to ...
Also found in: [+]
Soon, new drug for resistant prostate cancer 21.1.2015 TOI: Cities
Of the 7.6 million deaths due to cancer worldwide, one-sixth are caused by prostate cancer which is the second most frequently diagnosed cancer type after lung ...
Also found in: [+]
Patent refusal shock before Obama visit 19.1.2015 Telegraph: Nation
A week before US President Barack Obama and Prime Minister Narenda Modi jointly review the Republic Day parade, two Indias are engaged in a fierce competition to engage America.
Also found in: [+]
Why Indian startups like Bugworks, Vitas Pharma have entered the field of drug discovery 18.1.2015 ET: Pharma
The WHO’s first report on the global state of antibiotic-resistant bacteria recently warned that the world is entering a “postantibiotic era”, in which even the most powerful antibiotics available are becoming ineffective against infections so easily treated in the past.
Also found in: [+]
Nod for hepatitis C drug 18.1.2015 Telegraph: Nation
The country's drug regulatory agency has approved for marketing a medicine called sofosbuvir to treat hepatitis C virus infections.
Also found in: [+]
Novartis takes RTI route, blocks local firm's bid to copy anti-diabetes drug 17.1.2015 TOI: India Business
Swiss pharmaceutical giant Novartis has restrained a local pharma company from making anti-diabetes drug by approaching a court because the MNC had patented the drug and is enjoying monopoly over its production and sale.
Also found in: [+]
Gilead to challenge hepatitis C drug patent rejection decision 16.1.2015 ET: Healthcare
"The main patent applications covering sofosbuvir are still pending before the Indian Patent Office," Alton said.
Also found in: [+]
IPR won't be part of model law on fake drugs, says UN arm 16.1.2015 ET: Policy
The model legislative provisions have no relation to intellectual property rights and do not apply to unintentional quality defects.
Also found in: [+]
India’s refuses patent to Gilead for its drug Sovaldi 16.1.2015 ET: Pharma
The decision of the patent office comes at a time when India-US trade relations are seeing an uptick ahead of President Barack Obama’s visit.
Also found in: [+]
Fillip to cheaper hepatitis C drug 16.1.2015 Telegraph: Nation
India's patent regulating agency today rejected a US company's patent claim on a drug to treat hepatitis C, raising hopes that generic drug makers could now produce cheaper versions of the medicine.
Also found in: [+]
Compulsory licensing a recognised instrument, says WIPO chief Francis Gurry 15.1.2015 ET: Pharma
Terms and conditions are set up for its exercise but it is a recognized part of the international system,” Gurry said on Wednesday.
Also found in: [+]
1 to 20 of 2,530